15,000
Participants
Start Date
December 31, 2011
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
No intervention
This is an observational and a retrospective study of existing data, so there will be no interventions. The exposure groups will be domperidone, proton pump inhibitors (omeprazole, lansoprazole, esomeprazole, rabeprazole, and pantoprazole), and metoclopramide.
Janssen Research & Development, LLC
INDUSTRY